Although the role of NK cells in rejection of E1A-positive tumor cells is well established, the cellular mechanisms through which E1A renders tumor cells sensitive to NK killing and tumor challenge rejection are incompletely defined. The gene discussed is DHTKD1; the disease is neoplasm.